Modeling the Effect of Binding Kinetics in Spatial Drug Distribution in the Brain

A 3-dimensional mathematical model is developed to determine the effect of drug binding kinetics on the spatial distribution of a drug within the brain. The key components, namely, transport across the blood-brain barrier (BBB), drug distribution in the brain extracellular fluid (ECF), and drug bind...

Full description

Bibliographic Details
Main Authors: Nelson Kashaju, Mark Kimathi, Verdiana G. Masanja
Format: Article
Language:English
Published: Hindawi Limited 2021-01-01
Series:Computational and Mathematical Methods in Medicine
Online Access:http://dx.doi.org/10.1155/2021/5533886
id doaj-87945d4506bf4d50bbc763b795fb2b14
record_format Article
spelling doaj-87945d4506bf4d50bbc763b795fb2b142021-07-19T01:05:09ZengHindawi LimitedComputational and Mathematical Methods in Medicine1748-67182021-01-01202110.1155/2021/5533886Modeling the Effect of Binding Kinetics in Spatial Drug Distribution in the BrainNelson Kashaju0Mark Kimathi1Verdiana G. Masanja2Department of Applied Mathematics and Computational SciencesMathematics and Statistics DepartmentDepartment of Applied Mathematics and Computational SciencesA 3-dimensional mathematical model is developed to determine the effect of drug binding kinetics on the spatial distribution of a drug within the brain. The key components, namely, transport across the blood-brain barrier (BBB), drug distribution in the brain extracellular fluid (ECF), and drug binding kinetics are coupled with the bidirectional bulk flow of the brain ECF to enhance the visualization of drug concentration in the brain. The model is developed based on the cubical volume of a brain unit, which is a union of three subdomains: the brain ECF, the BBB, and the blood plasma. The model is a set of partial differential equations and the associated initial and boundary conditions through which the drug distribution process in the mentioned subdomains is described. Effects of drug binding kinetics are investigated by varying the binding parameter values for both nonspecific and specific binding sites. All variations of binding parameter values are discussed, and the results show the improved visualization of the effect of binding kinetics in the drug distribution within the brain. For more realistic visualization, we suggest incorporating more brain components that make up the large volume of the brain tissue.http://dx.doi.org/10.1155/2021/5533886
collection DOAJ
language English
format Article
sources DOAJ
author Nelson Kashaju
Mark Kimathi
Verdiana G. Masanja
spellingShingle Nelson Kashaju
Mark Kimathi
Verdiana G. Masanja
Modeling the Effect of Binding Kinetics in Spatial Drug Distribution in the Brain
Computational and Mathematical Methods in Medicine
author_facet Nelson Kashaju
Mark Kimathi
Verdiana G. Masanja
author_sort Nelson Kashaju
title Modeling the Effect of Binding Kinetics in Spatial Drug Distribution in the Brain
title_short Modeling the Effect of Binding Kinetics in Spatial Drug Distribution in the Brain
title_full Modeling the Effect of Binding Kinetics in Spatial Drug Distribution in the Brain
title_fullStr Modeling the Effect of Binding Kinetics in Spatial Drug Distribution in the Brain
title_full_unstemmed Modeling the Effect of Binding Kinetics in Spatial Drug Distribution in the Brain
title_sort modeling the effect of binding kinetics in spatial drug distribution in the brain
publisher Hindawi Limited
series Computational and Mathematical Methods in Medicine
issn 1748-6718
publishDate 2021-01-01
description A 3-dimensional mathematical model is developed to determine the effect of drug binding kinetics on the spatial distribution of a drug within the brain. The key components, namely, transport across the blood-brain barrier (BBB), drug distribution in the brain extracellular fluid (ECF), and drug binding kinetics are coupled with the bidirectional bulk flow of the brain ECF to enhance the visualization of drug concentration in the brain. The model is developed based on the cubical volume of a brain unit, which is a union of three subdomains: the brain ECF, the BBB, and the blood plasma. The model is a set of partial differential equations and the associated initial and boundary conditions through which the drug distribution process in the mentioned subdomains is described. Effects of drug binding kinetics are investigated by varying the binding parameter values for both nonspecific and specific binding sites. All variations of binding parameter values are discussed, and the results show the improved visualization of the effect of binding kinetics in the drug distribution within the brain. For more realistic visualization, we suggest incorporating more brain components that make up the large volume of the brain tissue.
url http://dx.doi.org/10.1155/2021/5533886
work_keys_str_mv AT nelsonkashaju modelingtheeffectofbindingkineticsinspatialdrugdistributioninthebrain
AT markkimathi modelingtheeffectofbindingkineticsinspatialdrugdistributioninthebrain
AT verdianagmasanja modelingtheeffectofbindingkineticsinspatialdrugdistributioninthebrain
_version_ 1721295452366700544